Skip to main content

A 15 Week, Phase 2, Double Blind, Randomized, Placebo-Controlled, Dose Ranging Study to Investigate the Efficacy, Safety and Tolerability of PF 06649751 in Subjects with Motor Fluctuations due to PD

Clinical Trial Grant
Duke Scholars

Administered By

Neurology, Movement Disorders

Awarded By

Pfizer, Inc.

Start Date

July 1, 2016

End Date

December 31, 2018
 

Administered By

Neurology, Movement Disorders

Awarded By

Pfizer, Inc.

Start Date

July 1, 2016

End Date

December 31, 2018